1. Scope #
Content describing DEFRATAJ (Deferasirox) is summary background information. It does not replace the locally approved SmPC / Package Insert / Prescribing Information.
2. Prescribing Decisions #
Prescribing, dosing, monitoring and safety decisions must be made by a qualified HCP.
3. No Doctor-Patient Relationship #
Use of this website does not create a doctor-patient relationship.
4. Country-Specific Status #
Approved indications, contraindications, warnings and dosing vary by country. Always consult local labelling.
5. Representative Outcomes #
Numerical outcomes cited are representative summary ranges from published data, not individualised predictions.
6. Adverse Event Reporting #
Report suspected ADRs to your local PV authority and pharmacovigilance@tajpharma.com - see Pharmacovigilance.
7. No Third-Party Endorsement #
References to third-party content do not constitute endorsement.
8. Emergencies #
For medical emergencies, contact local emergency services. Do not use this website for urgent care.